GNL Gut and Liver
  1. Victoria Chernyak, Kathryn J. Fowler, Jay P. Heiken, Claude B. Sirlin. Use of gadoxetate disodium in patients with chronic liver disease and its implications for liver imaging reporting and data system (LI-RADS). J. Magn. Reson. Imaging 2019;49:1236
    https://doi.org/10.1002/jmri.26540
  2. Hyo Jung Park, Tae Young Lee, So Yeon Kim, Min-Ju Kim, Amit G. Singal, So Jung Lee, Hyung Jin Won, Jae Ho Byun, Young-Suk Lim. Hypervascular transformation of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid–enhanced MRI: long-term follow-up in a surveillance cohort. Eur Radiol 2022;32:5064
    https://doi.org/10.1007/s00330-022-08623-8
  3. Seung-seob Kim, Sunyoung Lee, Myeong-Jin Kim. Prognostic factors of gadoxetic acid–enhanced MRI for postsurgical outcomes in multicentric hepatocellular carcinoma. Eur Radiol 2021;31:3405
    https://doi.org/10.1007/s00330-020-07419-y
  4. Feiqian Wang, Kazushi Numata, Makoto Chuma, Hiromi Nihonmatsu, Satoshi Moriya, Akito Nozaki, Katsuaki Ogushi, Hiroyuki Fukuda, Masahiro Okada, Litao Ruan, Wen Luo, Norihiro Koizumi, Masayuki Nakano, Masako Otani, Yoshiaki Inayama, Shin Maeda. The value of hepatobiliary phase in EOB-MRI in predicting hypervascularization outcome of non-hypervascular hypointense lesions in high-risk patients for hepatocellular carcinoma. Abdom Radiol 2021;46:2527
    https://doi.org/10.1007/s00261-020-02881-0
  5. Roberto Cannella, Federica Vernuccio, Hersh Sagreiya, Kingshuk Roy Choudhury, Negaur Iranpour, Daniele Marin, Alessandro Furlan. Liver Imaging Reporting and Data System (LI-RADS) v2018: diagnostic value of ancillary features favoring malignancy in hypervascular observations ≥ 10 mm at intermediate (LR-3) and high probability (LR-4) for hepatocellular carcinoma. Eur Radiol 2020;30:3770
    https://doi.org/10.1007/s00330-020-06698-9
  6. Jelena Djokic Kovac, Tamara Milovanovic, Vladimir Dugalic, Igor Dumic. Pearls and pitfalls in magnetic resonance imaging of hepatocellular carcinoma. WJG 2020;26:2012
    https://doi.org/10.3748/wjg.v26.i17.2012
  7. Tae-Hyung Kim, Sungmin Woo, Sangwon Han, Chong Hyun Suh, Richard Kinh Gian Do, Jeong Min Lee. Risk Factors for Hypervascularization in Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement: A Systematic Review and Meta-analysis. Academic Radiology 2022;29:198
    https://doi.org/10.1016/j.acra.2020.08.031
  8. Dong Kyu Kim, Chansik An, Yong Eun Chung, Jin-Young Choi, Joon Seok Lim, Mi-Suk Park, Myeong-Jin Kim. Hepatobiliary versus Extracellular MRI Contrast Agents in Hepatocellular Carcinoma Detection: Hepatobiliary Phase Features in Relation to Disease-free Survival. Radiology 2019;293:594
    https://doi.org/10.1148/radiol.2019190414
  9. Sonal Krishan, Radha K. Dhiman, Navin Kalra, Raju Sharma, Sanjay S. Baijal, Anil Arora, Ajay Gulati, Anu Eapan, Ashish Verma, Shyam Keshava, Amar Mukund, S. Deva, Ravi Chaudhary, Karthick Ganesan, Sunil Taneja, Ujjwal Gorsi, Shivanand Gamanagatti, Kumble S. Madhusudan, Pankaj Puri, Shalimar, Shallini Govil, Manav Wadhavan, Sanjiv Saigal, Ashish Kumar, Shallini Thapar, Ajay Duseja, Neeraj Saraf, Anubhav Khandelwal, Sumit Mukhopadyay, Ajay Gulati, Nitin Shetty, Nipun Verma. Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System. Journal of Clinical and Experimental Hepatology 2019;9:625
    https://doi.org/10.1016/j.jceh.2019.07.005
© 2023. Gut and Liver. / Powered by INFOrang Co., Ltd